Sergey Avtushenko
Directeur/Bestuurslid bij PHARMSYNTHEZ
Profiel
Sergey Sergeevich Avtushenko is currently the Director at Pharmsynthez PJSC and the Director at SynBio LLC.
Previously, he worked as the Executive Director at H & H LLC from 2003 to 2007 and as a Member-Management Board at Pharmavit Holding.
Mr. Avtushenko completed his undergraduate degree at Pavlov First Saint Petersburg State Medical University.
Actieve functies van Sergey Avtushenko
Bedrijven | Functie | Begin |
---|---|---|
PHARMSYNTHEZ | Directeur/Bestuurslid | - |
SynBio LLC
SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Sergey Avtushenko
Bedrijven | Functie | Einde |
---|---|---|
H & H LLC | Directeur/Bestuurslid | 01-01-2007 |
Pharmavit Holding | Corporate Officer/Principal | - |
Opleiding van Sergey Avtushenko
Pavlov First Saint Petersburg State Medical University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
PHARMSYNTHEZ | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
H & H LLC | |
Pharmavit Holding | |
SynBio LLC
SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation. | Health Technology |